The question
Are stable cancer stem-cell groups necessary for tumour survival and relapse?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Cancer Stem Cell Hypothesis
Are stable cancer stem-cell groups necessary for tumour survival and relapse?
What you need to knowCancer stem-cell roles can matter, but a universal fixed hierarchy fits less well than changing cell roles.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Cells move into or out of tumour-regrowing states depending on genes, surroundings and treatment.
Review summary
Claim assessed: Discrete self-renewing cancer stem-cell populations organized in stable hierarchies are necessary for tumour maintenance and post-treatment relapse across human cancers.
Finding: Γ for the exact registered broad fixed-hierarchy claim. The cancer rubric explicitly permits Ε for context-specific CSC validity; that threshold is awarded to SC2 and SC3 rather than silently replacing SC5 with a weaker functional-stemness statement. Across-context causal studies are credited as a convergent set, but their results include genuine population replacement, stage-specific dispensability and alternative lineage routes. They therefore do not cross the fixed cross-human necessity gate. Scope-matched and primary-subclaim aggregation both return Γ; weakest-link also returns Γ. Narrow existence is Ζ, and defined maintenance/relapse dependencies are Ε.
Key points
- SC1: Hierarchical organization with functionally distinct stem-like cells exists. — HSEF Ζ, Moderate confidence.
- SC2: A discrete CSC population is necessary for tumour maintenance. — HSEF Ε, Moderate confidence.
- SC3: CSCs are necessary for relapse after treatment. — HSEF Ε, Moderate confidence.
- SC4: The hierarchy is stable rather than a reversible cell state. — HSEF Γ, Moderate confidence.
- SC5: A fixed discrete CSC hierarchy is necessary across human cancers. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 68 primary reports; literature cutoff 2026-10-05; source examination UTC date 2026-10-06; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Cancer stem-cell roles can matter, but a universal fixed hierarchy fits less well than changing cell roles.
Read the labels in this illustration
THE MAIN FINDING The hierarchy is not a one-way ladder: differentiated cells can regain stem-like states. The idea Is the stem-cell hierarchy a one-way ladder from stem cells to specialised cells? Stem-like cells Differentiated cells Proposed one-way ladder — dashed arrows are not established The model under review What fits better Plasticity beats strict hierarchy Best fit in this review Stem-like cells Differentiated cells Cells can move back up — observed in lineage tracing Both directions observed Stem-like cells Differentiated cells Proposed one-way ladder — dashed arrows are not established Strict one-way — does not fit What remains uncertain How often dedifferentiation happens What signals trigger the return to stem-like states Whether this happens outside the models studied Evidence comes from cells and animals — each setting carries different weight. Lineage tracing shows differentiated cells regaining stem-like states and re-forming hierarchies. Conceptual illustration
Best fit in this review
Flexible cell roles within a tumour
Cells move into or out of tumour-regrowing states depending on genes, surroundings and treatment.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 5 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 5 among 5 compared models.
Leading explanation: Context-dependent hybrid hierarchy/plasticity.
Position in this comparison: Last recorded rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Is the stem-cell hierarchy a one-way ladder from stem cells to specialised cells? Proposed chain Stem-like cells Differentiated cells one way The single arrow is a proposal, not a proven step. Lineage tracing shows differentiated cells regaining stem-like states and re-forming hierarchies. B · Leading explanation Plasticity beats strict hierarchy Observed in lineage tracing Stem-like cells Differentiated cells Cells can move back up — observed in lineage tracing Differentiated cells can move back up Stem-like cells Differentiated cells Proposed one-way ladder — dashed arrows are not established Strict one-way ladder — does not fit A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 5
Are stable cancer stem-cell groups necessary for tumour survival and relapse?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Flexible cell roles within a tumour
Cells move into or out of tumour-regrowing states depending on genes, surroundings and treatment.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Context-dependent hybrid hierarchy/plasticity — Functional hierarchies coexist with changing membership and genetic/niche constraints.
Rank 2: Reversible state plasticity — Tumour cells can enter or leave self-renewing/therapy-resistant states.
Rank 3: Microenvironment-dependent stemness — Location and stromal or metabolic signals determine functional stemness.
Rank 4: Clonal evolution — Genetic subclones selected by therapy generate propagation and resistance.
Rank 5: Fixed CSC hierarchy — A discrete self-renewing apex has stable membership and is irreplaceable across human cancers.
What this means
?
Plausible, not established
Cancer stem-cell roles can matter, but a universal fixed hierarchy fits less well than changing cell roles.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Cells move into or out of tumour-regrowing states depending on genes, surroundings and treatment.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Flexible cell roles within a tumour. Cells move into or out of tumour-regrowing states depending on genes, surroundings and treatment.
What test tells them apart?
Track ancestry and changing cell state during treatment and tumour regrowth.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Test whether cells can move back up the hierarchy in a living tumour. then then Change the proposed cause Proposed test Label differentiated cells Damage the stem-like niche Block dedifferentiation signals No intervention — control Each arm changes one thing; the control changes nothing. Measure the relevant outcome Proposed test cells Cell identity over time Which cells gain or lose stem-like markers animals Lineage tracing Where each cell's descendants end up people Tumour architecture Whether hierarchy reforms after treatment Measured in every arm. Check the result independently Proposed test First team measures Second team repeats An independent check of the result. Same predictions, fresh eyes — no shared data until the end. This storyboard shows the logic of a test. It does not show a result. The question is whether cells can move back up the hierarchy in a living tumour. Conceptual illustration
A useful next question
Track ancestry and changing cell state during treatment and tumour regrowth.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: In prespecified AML and epithelial tumour cohorts, combine longitudinal clone/state tracking with selective depletion of the putative stable apex, an equally cytotoxic bulk-killing comparator and population-specific rescue; quantify replacement from negative states and durable maintenance/relapse. Use native human serial sampling and independent disease-relevant perturbation platforms rather than relying on one marker or host.
What would be measured: Clone ancestry, bidirectional transition frequencies, target engagement, total burden and durable relapse-free survival with prespecified state-replacement detection limits
Important controls: Marker-independent tracking; lineage-label induction controls; intact niche; normal stem-cell toxicity; orthogonal targeting; sham and matched bulk cytotoxicity; blinded relapse assessment; rescue without changing oncogenic drivers
Result that would support the claim: Irreplaceable fixed-apex depletion abolishes maintenance and recurrence across predefined classes, with selective rescue restoring both and no regeneration from negative cells
Result that would count against it: Negative cells or alternate states sustain disease or regenerate the apex; selective depletion fails despite verified engagement, or benefit tracks generalized killing rather than state dependency
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →